Detalhe da pesquisa
1.
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.
Nature
; 615(7954): 920-924, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922593
2.
Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease.
Blood
; 141(4): 335-344, 2023 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040484
3.
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood
; 142(8): 700-710, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319437
4.
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
J Allergy Clin Immunol
; 151(1): 260-271, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987350
5.
Mixed donor chimerism following stem cell transplantation for sickle cell disease.
Curr Opin Hematol
; 30(6): 187-193, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37694765
6.
Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation.
Pediatr Blood Cancer
; 70 Suppl 6: e30577, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480158
7.
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders.
J Allergy Clin Immunol
; 149(3): 1097-1104.e2, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34375618
8.
Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.
Blood
; 136(5): 623-626, 2020 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32518950
9.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood
; 135(23): 2094-2105, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268350
10.
Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies.
Transfus Apher Sci
; 61(5): 103554, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096996
11.
How I treat sickle cell disease with hematopoietic cell transplantation.
Blood
; 134(25): 2249-2260, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697818
12.
A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
Transfusion
; 61(3): 894-902, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475172
13.
A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study.
Biol Blood Marrow Transplant
; 26(4): 712-717, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870931
14.
Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
J Clin Immunol
; 40(8): 1211-1213, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860171
15.
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
Blood
; 132(13): 1438-1451, 2018 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997222
16.
A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.
Pediatr Blood Cancer
; 67(1): e28030, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31599480
17.
Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.
Biol Blood Marrow Transplant
; 25(5): e174-e178, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30639825
18.
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.
Biol Blood Marrow Transplant
; 25(3): 556-561, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30321596
19.
Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.
Biol Blood Marrow Transplant
; 25(5): 955-964, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30605731
20.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423480